Pilani

First class M.Pharm or M.S. Pharm in Pharmacology, Pharmacology and Toxicology, Regulatory Toxicology, Pharmaceutics, Pharmacetical biotechnology etc.

First class in M.Pharm. or M.S. in Pharmaceutics, Drug delivery, Pharmaceutical Technology, Nanomedicines, or equivalent from a recognized Institute, University.

Masters Degree in Pharmaceutics or Pharmaceutical Sciences from a recognized university. BITS Pilani

Research Associate, Research Staff will carry perform experimental work related to compositional analysis and process optimization of formulations. Additionally, he/she will operate and maintain analytical instruments such as HPLC, UV-Vis, FTIR, etc

Ph.D. in pharmacy or biological sciences or equivalent from a recognized University. Candidate with experience in the nanoformulations, cell culture studies and animal handling will be preferred. Those who have submitted their PhD thesis and are awaiting award of the degree are also eligible to apply.

All the full-time Ph.D. students admitted into the Ph.D. program will receive fellowship up to a maximum of five years. The fellowship could be from the Institute or Sponsored Projects. Ph.D. students may also have their own fellowship if qualified through UGC/CSIR NET.

The candidate will carry out the proposed work of the project. He, She will validate the in-vitro and in-vivo DKD model and conduct molecular biology experiments and data analysis. Well-versed in animal handling, in-vitro work, molecular biology techniques, and pharmacology work. He, she will also write the research papers in indexed journals, conferences, and patents.

First class in Masters Degree with specialization in Biotech, Cancer Biology, Epigenetics, Molecular Biology, Cell Biology, Nanoscience and Nanotechnology from a recognized University with good knowledge of molecular biology plud GATE, NET qualified

First class in M.Pharm with specialization in Pharmaceutics or equivalent from a recognized University Candidate with industrial experience in formulation development, drug delivery, medical devices will be given preference.